ha14-1 has been researched along with Cancer of Cervix in 1 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, N | 1 |
| Kataoka, K | 1 |
| Sora, S | 1 |
| Hara, T | 1 |
| Omura-Minamisawa, M | 1 |
| Funayama, T | 1 |
| Sakashita, T | 1 |
| Nakano, T | 1 |
| Kobayashi, Y | 1 |
1 other study available for ha14-1 and Cancer of Cervix
| Article | Year |
|---|---|
The small-molecule Bcl-2 inhibitor HA14-1 sensitizes cervical cancer cells, but not normal fibroblasts, to heavy-ion radiation.
Topics: Benzopyrans; Cell Death; Cell Survival; Female; Fibroblasts; Heavy Ions; Humans; Nitriles; Photosens | 2008 |